Village prepares to welcome runners to 40th anniversary charity race
A Dorset village is preparing to welcome runners to a popular race event.
Tarrant Monkton and the Langton Arms pub are gearing up for the annual Tarrant Valley 10 (TV10) race, which will take place on Sunday, June 1.
This year marks the 40th anniversary of the event, which began in 1985, and will see both adult and children's races.
The main 10km race will start at 10.30am and will be followed by a one-mile children's race.
READ MORE: Charity seeking volunteers to help expand social groups
This year marks the 40th anniversary of the race (Image: Tarrant Valley 10) To commemorate the anniversary, each runner will receive a special medal, with the children's race participants also included.
New prize categories have also been introduced this year, recognising the first male over 70, the first female over 65 and the first male and female under 20.
Spectators and supporters can enjoy a barbecue, ice-creams, teas, coffees and a raffle.
The adult's 10km race and the children's one-mile run will be chip-timed by Rogue Racer.
All runners will receive printable certificates, and the day will be documented with numerous photographs.
SEE MORE: Children's charity inviting cyclists to take part in 40-mile ride
The Langton Arms pub, owned by local farmers James and Barbara Cossins, will be supporting the event.
Known for its locally sourced menu, the pub will be open for bookings for lunch after the races.
The event, which is not-for-profit, will donate its proceeds to two charities: the Dorset and Somerset Air Ambulance and Horatio's Garden.
The air ambulance service, which is funded by donations, carried out almost 3,000 missions last year and is viewed as a vital service, especially for rural villages.
Horatio's Garden creates garden sanctuaries attached to NHS Spinal Injury Centres, providing rest and respite for people with spinal injuries.
Organisers are encouraging people to pre-book online at tarrantvalley10.org, with a saving of at least £5 compared to the on-the-day price.
The starter whistle will blow at 10.30am in Tarrant Monkton, DT11 8RX.
The TV10, which is run through the picturesque Cranborne Chase countryside, has been a staple in the local community for four decades and continues to be a great opportunity for runners of all abilities to take part.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
Concerns raised around mental health care as MP calls for ‘urgent' action
A healthcare watchdog carried out an inspection of mental health wards for older people in Greater Manchester after receiving 'concerning information' from whistleblowers. Pennine Care NHS Foundation Trust provides mental health services across Greater Manchester, including units at Fairfield General Hospital, Birch Hill Hospital and Royal Oldham Hospital. It was assessed by the Quality Care Commission (CQC) in November last year in response to 'concerning information' received about several mental health wards from complaints, whistleblowing concerns and notifications from the trust. The assessment included onsite inspections of all nine of the trust's wards. The report, which was published in May, found five breaches of regulations and highlighted concerns around staffing, patient care and training. Inspectors found that patients did not always receive "sufficient person-centred support to make their own decisions". Get the latest news delivered straight to your inbox by signing up to the Bury Times morning newsletter as well as our breaking news alerts. The report said that patients who were unable to clearly communicate their needs verbally "did not have communication care plans or any planned individualised support to support them in making and communicating decisions about their care". For patients who might have impaired mental capacity, staff "did not always assess and record capacity to consent appropriately". It added that relatives and carers "mostly gave positive feedback" but that some reported that they were "only allowed an hour with their relatives". Inspectors found that it was "not possible" to identify the proportion of staff on each ward who had completed Mental Health Act awareness training or how up to date this was due to it not being compulsory. The service "did not have effective arrangements to monitor adherence to the Mental Capacity Act" at the time of the visit and the trust was not carrying out regular audits to ensure that the Mental Health Act was being applied correctly. The report found that although the wards were "usually staffed to safe levels", there was "high use" of temporary staff to cover vacancies, staff sickness and enhanced clinical need on the wards. It also shared that the systems for induction and training of temporary staff "did not always ensure that staff were familiar with the wards and the needs of the patients they were caring for". READ NEXT: Eight Bury schools set to receive share of £54m funding for essential work READ NEXT: Greater Manchester to get £2.5bn transport boost- including new Bury tram stop While "most" patients told inspectors that the food was "good", some said that "good quality food which met their cultural needs was not always available" and that they did not have access to spiritual support on the ward when they "would have liked this". The CQC has instructed the trust to provide an action plan and to make improvements in response to the concerns found. Bury North MP James Frith deemed the findings 'unacceptable' and has written to the trust's chief executive demanding 'urgent answers and action' along with an immediate meeting. The Labour MP said: 'The CQC's findings are deeply troubling. "Older people in Bury deserve far better than wards that fall short on safety, staffing, and care. 'Since sharing my letter, I've been contacted by families of patients who've come forward with their own experiences – adding weight to the serious concerns raised. 'I've written to the trust demanding urgent improvements to ensure dignity, safety, and proper treatment for some of our most vulnerable residents.' The trust also provides mental health services for military veterans across Greater Manchester. The overall rating of the trust's wards for older people with mental health needs has dropped from its former "good" status to "requires improvement". READ NEXT: Up to 120 taxi drivers in Bury face 'immediate suspension' READ NEXT: Work to start on replacement for bridge destroyed a decade ago Tim McDougall, executive director of quality, nursing and healthcare professionals at Pennine Care NHS, said: 'We accept the findings of the CQC's assessment of our older adult mental health wards and are fully committed to addressing the areas identified for improvement. 'Our focus is on delivering high-quality, person-centred care for all our patients. 'While the inspection highlighted challenges, it also recognised positive practice - the compassionate care of staff, clean and safe ward environments, and our culture of safety and openness. 'We are already delivering a robust improvement plan focused on strengthening clinical standards, patient engagement, staff training and ward leadership. 'We're also improving compliance with mental health law, access to therapeutic activities and work to further embed a culture of kindness, respect and safety. 'Importantly, we are working in partnership with patients, carers and staff to ensure lasting change. 'We're proud our efforts are reflected in our latest NHS Staff Survey results which showed improvements across all seven themes, scores above the national average, and recognition as the best mental health and learning disability trust to work for in the North.'
Yahoo
6 days ago
- Yahoo
AI to help end ‘postcode lottery' for vital prostate cancer drug
AI could bring an end to the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers have said. A study has discovered that the technology can identify the patients who will benefit most from a "game changer" drug. Abiraterone, a hormone therapy that blocks testosterone production to prevent the growth of prostate cancer, is approved for NHS use in England for patients with advanced prostate cancer that has spread. However, it is not approved for men newly diagnosed with high-risk prostate cancer that has not yet spread, even though it has been available for these patients in Scotland and Wales for the past two years. The new test, developed by Artera, uses AI to detect features invisible to the human eye on images of tumour samples. The study, led by The Institute of Cancer Research, London, and University College London (UCL), ran the test on biopsy images from more than 1,000 men who took part in the Stampede trial. Patients were given a score of either biomarker-positive or biomarker-negative. Researchers found abiraterone reduced the risk of death among biomarker-positive patients from 17 per cent to 9 per cent. In biomarker-negative patients, the drug cut death risk from 7 per cent to 4 per cent, with researchers suggesting this indicates these men would benefit from standard therapy. Nick James, a professor of prostate and bladder cancer research at The Institute of Cancer Research, London, and consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, is chief investigator of Stampede and co-led the new study. He said: 'This research shows that we can pick out the people who will respond best to abiraterone, and those who will do well from standard treatment alone – hormone therapy and radiotherapy. 'Access to this life-extending drug is currently a postcode lottery – with those living in Scotland and Wales able to receive the treatment for free. 'The NHS in England has previously decided that it would be too expensive to offer the drug. Since the patent expired in 2022, abiraterone costs just £77 per pack – compared with the thousands of pounds that new drugs cost. 'Previous research by my team has shown that preventing cancer relapses for these men would save more money than the drug costs to purchase. 'I truly hope that this new research – showing precisely who needs the drug to live well for longer – will lead to NHS England reviewing their decision not to fund abiraterone for high-risk prostate cancer that has not spread.' Prof James also highlighted that while abiraterone can have 'spectacular' results, it does have side effects. 'Abiraterone has already hugely improved the outlook for hundreds of thousands of men with advanced prostate cancer,' he said. 'We know that for many men with cancer that has not yet spread, it can also have spectacular results. 'But it does come with side effects and requires additional monitoring for potential issues with high blood pressure or liver abnormalities. 'It can also slightly increase the risk of diabetes and heart attacks, so knowing who is most likely to benefit is very valuable.' Experts hope the findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, may lead to a change in the availability of abiraterone in England. Prof Kristian Helin, chief executive of The Institute of Cancer Research, said the drug has been a 'game changer for treatment of prostate cancer'. 'Alongside our mission to find smarter, kinder treatments, we must ensure we are matching the right drugs to the right patients,' he added. 'This research, using artificial intelligence, provides an innovative route to testing prostate cancer patients to determine their treatment. 'I hope that this can be implemented so that all men with prostate cancer who will benefit from abiraterone can do so.' Dr Matthew Hobbs, director of research at Prostate Cancer UK, said: 'Prostate Cancer UK has been calling on the UK Government to approve this life-saving, cost-effective drug for over two years. 'These exciting results suggest a way to make this an even more cost-effective approach. 'We therefore echo the researchers' urgent call for abiraterone to be made available to those men whose lives it can save – men who, thanks to this research, we can now identify more precisely than ever before.'
Washington Post
6 days ago
- Washington Post
England selects froward Lauren James for Women's Euros despite injury concern
LONDON — Chelsea forward Lauren James was picked in England's 23-woman squad for its title defense in the Women's European Championship on Thursday despite having not played a game for club or country since early April because of injury. James injured a hamstring against Belgium on April 4 and was the biggest doubt ahead of England coach Sarina Wiegman's squad selection. However, she was included among the attacking options, which also featured Michelle Agyemang, a highly rated 19-year-old forward who has played once for England. Wiegman will be without 218 caps worth of experience in the wake of Millie Bright's decision to pull out of selection because of health reasons and following the international retirements of Mary Earps and Fran Kirby over the past week. England's first game at the Euros, taking place in Switzerland, is against France on July 5. ___ AP soccer:
